# State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD (HEAW)

**Source:** https://fundology.uk/fund/heaw · ISIN IE00BYTRRB94 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, HEAW (State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD, ISIN IE00BYTRRB94) closed at £54.13 on the London Stock Exchange. Its ongoing charge is 0.30% a year (about £30 on £10,000). Over the five years to 30/09/2026 its total return was +32.4%, or +3.5% after UK CPIH inflation.

## Summary

State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD is an exchange-traded fund (ETF) from SPDR, launched in 2016. It tracks the MSCI World Health Care 35/20 Capped Index - Benchmark TR Net — about 1,300 large and medium-sized companies in 23 developed countries, around 70% of it in the US. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.3% a year — about £30 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£54.13** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | HEAW |
| ISIN | IE00BYTRRB94 |
| Category | Healthcare |
| Type | ETF |
| Provider | SPDR |
| Tracks | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.30% a year (£30 per £10,000) |
| Fund size | £399m |
| Launched | 2016 |
| Domicile | Ireland |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +22.35% | +18.51% | income reinvested |
| 3 years | +20.50% | +8.73% | income reinvested |
| 5 years | +32.36% | +3.47% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Charges compared with similar funds

Ongoing charge of State Street SPDR MSCI World Health Care UCITS ETF Accum.Ptg. USD 0.30% a year, as of 01/10/2026: 5 of the 17 other healthcare funds charge more, 2 the same and 10 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.30%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 30/09/2026):

| Holding | Weight |
|---|---|
| Eli Lilly and | 11.13% |
| Johnson & Johnson | 7.66% |
| AbbVie | 5.55% |
| Merck | 4.31% |
| UnitedHealth Group | 4.01% |
| Roche | 3.68% |
| Novartis | 3.16% |
| Thermo Fisher Scientific | 3.02% |
| AstraZeneca | 2.96% |
| Amgen | 2.73% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By country

Added up from the holdings SPDR publishes, as of 30/09/2026.

| Country | Weight |
|---|---|
| United States | 74.0% |
| Switzerland | 9.0% |
| United Kingdom | 4.8% |
| Japan | 3.4% |
| France | 2.0% |
| Denmark | 1.9% |
| Germany | 1.6% |
| Belgium | 1.1% |
| Other countries | 2.2% |

All 110 holdings: https://fundology.uk/fund/heaw/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.